Avadel Pharmaceuticals plc (NASDAQ:AVDL) Q4 2024 Earnings Call Transcript March 3, 2025
Avadel Pharmaceuticals plc reports earnings inline with expectations. Reported EPS is $-0.05 EPS, expectations were $-0.05.
Operator: Greetings, and welcome to Avadel Pharmaceuticals’ Fourth Quarter and Business Update Conference Call. At this time, all participants are in a listen-only mode. Accompanying slides for this call can be found on Avadel’s Investor Relations website. A question-and-answer...
